Arbutus Biopharma Corp Proceeds from Sale of Short-term Investments
Arbutus Biopharma Corp (ABUS) reported Proceeds from Sale of Short-term Investments of $37.36 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfShortTermInvestments · last filed 2015-05-06
CAD
| Period end | Proceeds from Sale of Short-term Investments 12 month |
|---|---|
| 2009-12-31 | 5.73M CAD 20-F · filed 2012-03-27 |
USD
| Period end | Proceeds from Sale of Short-term Investments 3 month |
|---|---|
| 2015-03-31 | $37.36M 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |